Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-05-25
1990-05-15
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514926, 514927, A61K 3135
Patent
active
049258702
ABSTRACT:
There is described a process for preparing proanthocyanidine A2 by extraction from cortex or fruits of Aesculus hippocastanum and related species and its activity for stimulating healing processes, e.g. healing wounds and injuries of various origins, gastric and duodenal ulcers for modifying conditions of impaired capillary permeability and resistance and for obtaining an anti-lipid peroxidation effect.
There are also described pharmaceutical formulations suitable for use by topical and systemic routes.
REFERENCES:
patent: 4258055 (1981-03-01), Lietti et al.
Dostert Philippe
Gabetta Bruno
Magistretti Maria J.
Inverni Della Beffa SpA
Societe de Recherches Industrielles (Sori)
Waddell Frederick E.
LandOfFree
Therapeutic use of proanthocyanidine A2 as a cytoprotective agen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic use of proanthocyanidine A2 as a cytoprotective agen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of proanthocyanidine A2 as a cytoprotective agen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-621850